![Paul M. Keane](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paul M. Keane
Geen lopende functies
Loopbaan van Paul M. Keane
Eerdere bekende functies van Paul M. Keane
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Bayer, Inc.
![]() Bayer, Inc. Chemicals: AgriculturalProcess Industries Bayer, Inc. manufactures chemicals, healthcare, agricultural, and life science products. The company develops products that fight diseases, protects crops and animals, as well as develops materials. It was founded in 1936 and is headquartered in Toronto, Canada | Hoofd Techniek/Wetenschap/O&O | 01-01-1989 | 01-01-1995 |
McMaster University | Corporate Officer/Principal | - | - |
University of Calgary | Corporate Officer/Principal | - | - |
YM BioSciences, Inc.
![]() YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | Hoofd Techniek/Wetenschap/O&O | 01-01-1996 | - |
Statistieken
Internationaal
Canada | 4 |
Verenigd Koninkrijk | 2 |
Operationeel
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 2 |
Sectoraal
Consumer Services | 3 |
Health Technology | 2 |
Process Industries | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
YM BioSciences, Inc.
![]() YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | Health Technology |
Bayer, Inc.
![]() Bayer, Inc. Chemicals: AgriculturalProcess Industries Bayer, Inc. manufactures chemicals, healthcare, agricultural, and life science products. The company develops products that fight diseases, protects crops and animals, as well as develops materials. It was founded in 1936 and is headquartered in Toronto, Canada | Process Industries |
- Beurs
- Insiders
- Paul M. Keane
- Ervaring